Position in OGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$297
+$167 QoQ
Shares Held
22
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#552
of 625 holders
Holding Since
Sep 2021
5 quarters on record
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KELLEHER FINANCIAL ADVISORS holds $17,885,890 across 12 Drug Manufacturers - General names. OGN ranks #12 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
17,508 | $4,405,712 | |
| 2 | JNJ |
Johnson & Johnson
|
12,574 | $3,193,418 | |
| 3 | LLY |
ELI LILLY & Co
|
2,498 | $2,996,175 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
17,214 | $2,174,816 | |
| 5 | AMGN |
Amgen Inc
|
5,256 | $1,903,301 | |
| 6 | MRK |
Merck & Co., Inc.
|
12,663 | $1,627,195 | |
| 7 | PFE |
Pfizer Inc
|
51,109 | $1,230,703 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,625 | $208,872 |
All Filings in OGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $297 | 22 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $130 | 22 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $149 | 21 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $512 | 48 | Shares | Sole | 2025-11-14 | |
| 2021-09-30 | $19,674 | 600 | Shares | Other | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||